These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22871352)
1. Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Clifford HD; Hayden CM; Khoo SK; Naniche D; Mandomando IM; Zhang G; Richmond P; Le Souëf PN Vaccine; 2012 Sep; 30(43):6180-5. PubMed ID: 22871352 [TBL] [Abstract][Full Text] [Related]
2. Genetic Variants in the IL-4/IL-13 Pathway Influence Measles Vaccine Responses and Vaccine Failure in Children from Mozambique. Clifford HD; Hayden CM; Khoo SK; Naniche D; Mandomando IM; Zhang G; Richmond P; Le Souëf PN Viral Immunol; 2017 Sep; 30(7):472-478. PubMed ID: 28594599 [TBL] [Abstract][Full Text] [Related]
3. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. Dhiman N; Poland GA; Cunningham JM; Jacobson RM; Ovsyannikova IG; Vierkant RA; Wu Y; Pankratz VS J Allergy Clin Immunol; 2007 Sep; 120(3):666-72. PubMed ID: 17560639 [TBL] [Abstract][Full Text] [Related]
4. SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine. Clifford HD; Richmond P; Khoo SK; Zhang G; Yerkovich ST; Le Souëf PN; Hayden CM Vaccine; 2011 Jul; 29(33):5407-13. PubMed ID: 21645571 [TBL] [Abstract][Full Text] [Related]
5. Impact of CD14 promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique. Clifford HD; Hayden CM; Khoo SK; Naniche D; Mandomando IM; Zhang G; Richmond P; Le Souëf PN Tissue Antigens; 2013 Dec; 82(6):420-2. PubMed ID: 24147858 [No Abstract] [Full Text] [Related]
6. Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine. Clifford HD; Yerkovich ST; Khoo SK; Zhang G; Upham J; Le Souëf PN; Richmond P; Hayden CM Immunogenetics; 2012 Mar; 64(3):219-28. PubMed ID: 21947541 [TBL] [Abstract][Full Text] [Related]
7. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months. Cutts FT; Monteiro O; Tabard P; Cliff J Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642 [TBL] [Abstract][Full Text] [Related]
8. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay. Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822 [TBL] [Abstract][Full Text] [Related]
9. CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children. Clifford HD; Hayden CM; Khoo SK; Zhang G; Le Souëf PN; Richmond P Clin Vaccine Immunol; 2012 May; 19(5):704-10. PubMed ID: 22357652 [TBL] [Abstract][Full Text] [Related]
12. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)]. Wiedermann G; Ambrosch F Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537 [TBL] [Abstract][Full Text] [Related]
13. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371 [TBL] [Abstract][Full Text] [Related]
14. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy. Yuan L CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189 [TBL] [Abstract][Full Text] [Related]
15. Two-dose measles vaccination schedules. Rosenthal SR; Clements CJ Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862 [TBL] [Abstract][Full Text] [Related]
16. The role of herd immunity in control of measles. Black FL Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027 [TBL] [Abstract][Full Text] [Related]
17. Antibody response after measles immunization. Ariyasriwatana C; Kalayanarooj S; Pattamadilok S J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170 [TBL] [Abstract][Full Text] [Related]
18. Measles epidemiology and outbreak response immunization in a rural community in Peru. Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877 [TBL] [Abstract][Full Text] [Related]
19. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda. Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111 [TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]